Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacopo Costa

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Oncology (Toronto, Ont.)|February 25, 2025
Oligometastatic NSCLC: Current Perspectives and Future ChallengesSara Torresan, Jacopo Costa, Carol Zanchetta, et al.
International Journal of Molecular Sciences|January 11, 2025
Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: State of the Art and Future PerspectivesCarol Zanchetta, Lorenzo De Marchi, Marianna Macerelli, et al.
International Journal of Molecular Sciences|January 8, 2025
The Role of ctDNA in the Management of Non-Small-Cell Lung Cancer in the AI and NGS EraJacopo Costa, Alexandro Membrino, Carol Zanchetta, et al.
Cancers|June 26, 2026
Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now?Luisa Piccin, Valentina Guarneri, Michele Del Vecchio, et al.
Cancers|June 12, 2026
Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future DirectionsFederico Pravisano, Jacopo Costa, Lorenzo De Marchi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Oncology (Toronto, Ont.)|February 25, 2025
Oligometastatic NSCLC: Current Perspectives and Future ChallengesSara Torresan, Jacopo Costa, Carol Zanchetta, et al.
International Journal of Molecular Sciences|January 11, 2025
Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: State of the Art and Future PerspectivesCarol Zanchetta, Lorenzo De Marchi, Marianna Macerelli, et al.
International Journal of Molecular Sciences|January 8, 2025
The Role of ctDNA in the Management of Non-Small-Cell Lung Cancer in the AI and NGS EraJacopo Costa, Alexandro Membrino, Carol Zanchetta, et al.
Cancers|June 26, 2026
Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now?Luisa Piccin, Valentina Guarneri, Michele Del Vecchio, et al.
Cancers|June 12, 2026
Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future DirectionsFederico Pravisano, Jacopo Costa, Lorenzo De Marchi, et al.
Pageof 1